chlorpromazine has been researched along with orphenadrine in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 28 (73.68) | 18.7374 |
1990's | 1 (2.63) | 18.2507 |
2000's | 4 (10.53) | 29.6817 |
2010's | 5 (13.16) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Bailey, AM; Paulsen, IT; Piddock, LJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Sen, S; Sinha, N | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Lader, MH | 1 |
Bartlett, W; Bourne, RC; Cotes, PM; Crow, TJ; Johnstone, EC | 1 |
Curry, S; Lader, M; Loga, S | 1 |
Ballatori, E; Basurto, C; Minotti, V; Roila, F; Tonato, M | 1 |
Bowers, MB; Roth, RH | 1 |
Bamji, AN; Bender, DA | 1 |
Bennett, JM | 1 |
Dols, LC; van Praag, HM | 1 |
Andersen, PR; Gibbs, P; Kubinski, H | 1 |
Beall, JR | 1 |
Bhargava, KP; Dixit, KS; Sinha, JN; Srimal, RC | 1 |
Ban, T; Hojo, M | 1 |
Bertuzzi, F; Dogliani, P; Senini, G | 1 |
Schipper, JA | 1 |
Roberts, E; Varon, S; Weinstein, H | 1 |
Castelli, G; Nardini, L | 1 |
Osuide, G | 1 |
Boersma, L; van Riezen, H | 1 |
Ginzel, KH; Kimison, R | 1 |
Ekdawi, MY; Fowke, R | 1 |
Buckle, RM; Guillebaud, J | 1 |
Pigache, RM | 1 |
Catalán Arlandis, JL; Jiménez Torres, NV | 1 |
BEGHI, Q | 1 |
PERRIN, J; SCHNEIDER, J; SIFFERMANN, A; THOMALSKE, G | 1 |
FROGEL, M | 1 |
TAIT, AC; TODRICK, A; YATES, CM | 1 |
DEMEL, RA | 1 |
GOLDSTEIN, L; MURPHREE, HB; PFEIFFER, CC; SUGERMAN, AA | 1 |
1 review(s) available for chlorpromazine and orphenadrine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 trial(s) available for chlorpromazine and orphenadrine
Article | Year |
---|---|
Neuroendocrine changes in acute schizophrenia as a function of clinical state and neuroleptic medication.
Topics: Acute Disease; Chlorpromazine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Flupenthixol; Follicle Stimulating Hormone; Growth Hormone; Humans; Luteinizing Hormone; Orphenadrine; Prolactin; Receptors, Dopamine; Schizophrenia; Testosterone; Thioxanthenes | 1978 |
Interactions of orphenadrine and phenobarbitone with chlorpromazine: plasma concentrations and effects in man.
Topics: Adult; Antipyrine; Chlorpromazine; Clinical Trials as Topic; Drug Interactions; Female; Half-Life; Humans; Male; Orphenadrine; Phenobarbital; Psychotic Disorders | 1975 |
Fluphenazine enanthate and fluphenazine decanoate: a comparison of their duration of action and motor side effects.
Topics: Acute Disease; Adult; Aged; Chlorpromazine; Clinical Trials as Topic; Esters; Female; Fluphenazine; Humans; Injections, Intramuscular; Male; Middle Aged; Movement Disorders; Orphenadrine; Placebos; Psychiatric Status Rating Scales; Psychotic Disorders; Time Factors | 1973 |
[Depot-neuroleptics in the treatment of schizophrenia].
Topics: Adult; Chlorpromazine; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Middle Aged; Orphenadrine; Perphenazine; Schizophrenia; Thioridazine | 1971 |
Effects of placebo, orphenadrine, and rising doses of chlorpromazine, on PAT performance in chronic schizophrenia. A two year longitudinal study.
Topics: Adult; Attention; Chlorpromazine; Chronic Disease; Dominance, Cerebral; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Humans; Length of Stay; Longitudinal Studies; Male; Middle Aged; Orphenadrine; Psychiatric Status Rating Scales; Reaction Time; Recurrence; Schizophrenia; Schizophrenic Psychology; Speech Perception | 1993 |
32 other study(ies) available for chlorpromazine and orphenadrine
Article | Year |
---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
Topics: Anti-Bacterial Agents; Antipsychotic Agents; Bacterial Proteins; Base Sequence; Chlorpromazine; DNA Primers; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ethidium; Gene Expression; Genes, Bacterial; Humans; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation; Oligonucleotide Array Sequence Analysis; Phenothiazines; Salmonella typhimurium; Trans-Activators | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
[Rational utilization of the major tranquilizers].
Topics: Adult; Antipsychotic Agents; Antipyrine; Chlorpromazine; Drug Interactions; Drug Therapy, Combination; Drug Utilization; Electroencephalography; Half-Life; Humans; Liver; Male; Orphenadrine; Phenobarbital; Psychotic Disorders; Theta Rhythm; Time Factors | 1975 |
A phase II antiemetic combination (COMD) for cisplatin-induced nausea and vomiting.
Topics: Adult; Aged; Antiemetics; Chlorpromazine; Dexamethasone; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Metoclopramide; Middle Aged; Orphenadrine | 1986 |
Interaction of atropine-like drugs with dopamine-containing neurones in rat brain.
Topics: Animals; Atropine; Benztropine; Brain; Chlorpromazine; Dopamine; Homovanillic Acid; Male; Methyltyrosines; Neurons; Orphenadrine; Phenothiazines; Procyclidine; Rats; Time Factors; Trihexyphenidyl | 1972 |
Serum tryptophan binding in chlorpromazine-treated chronic schizophrenics.
Topics: Chlorpromazine; Chronic Disease; Diffusion; Fatty Acids, Nonesterified; Humans; Liver; Male; Orphenadrine; Protein Binding; Schizophrenia; Serum Albumin; Time Factors; Tryptophan; Tryptophan Oxygenase | 1974 |
Modification of strychnine-induced convulsions by anticonvulsants in the frog.
Topics: Animals; Anticonvulsants; Anura; Chlorpromazine; Mephenesin; Muscle Contraction; Orphenadrine; Rana temporaria; Reserpine; Seizures; Strychnine | 1972 |
Effects of neuropharmacological agents on in vitro formation of complexes between nucleic acids and proteins.
Topics: Animals; Benztropine; Cattle; Chlorpromazine; Codeine; Desipramine; DNA, Bacterial; Escherichia coli; Histones; Lysergic Acid Diethylamide; Morphine; Neostigmine; Nucleic Acids; Orphenadrine; Phenytoin; Protein Binding; Proteins; RNA, Bacterial; RNA, Ribosomal; Serum Albumin, Bovine; Sodium Dodecyl Sulfate; Trihexyphenidyl | 1974 |
A teratogenic study of chlorpromazine, orphenadrine, perphenzaine, and LSD-25 in rats.
Topics: Abnormalities, Drug-Induced; Animals; Birth Weight; Chlorpromazine; Embryo Implantation; Evaluation Studies as Topic; Female; Gestational Age; Lysergic Acid Diethylamide; Male; Orphenadrine; Perphenazine; Pregnancy; Pregnancy, Animal; Rats; Rats, Inbred Strains; Reproduction | 1972 |
Central muscle relaxant activity of a dozen CNS active agents and a correlation with their psychotropic activity.
Topics: Amphetamine; Animals; Antidepressive Agents; Blood Pressure; Cats; Central Nervous System; Chlorpromazine; Desipramine; Dibenzothiazepines; Ephedrine; Female; Imipramine; Iproniazid; Male; Mephenesin; Monoamine Oxidase Inhibitors; Muscles; Orphenadrine; Phenelzine; Reflex; Thioridazine; Tranquilizing Agents | 1968 |
Comparison of the electroencephalographic and motor effects of orphenadrine, an antiparkinson agent.
Topics: Animals; Arousal; Atropine; Brain; Chlorpromazine; Depression, Chemical; Electric Stimulation; Electroencephalography; Injections, Intravenous; Male; Mephenesin; Motor Activity; Orphenadrine; Pentobarbital; Rabbits; Scopolamine; Stimulation, Chemical; Tectum Mesencephali | 1968 |
Clinical observations on the therapeutic activity of flupentixol in the treatment of chronic schizophrenia.
Topics: Adult; Aged; Blood; Body Weight; Chlorpromazine; Chronic Disease; Delusions; Depression, Chemical; Female; Hallucinations; Humans; Hypnotics and Sedatives; Male; Middle Aged; Orphenadrine; Parkinson Disease, Secondary; Piperazines; Psychomotor Disorders; Psychopharmacology; Schizophrenia; Social Behavior; Stimulation, Chemical; Transaminases; Xanthenes | 1970 |
Effects of imipramine on the Na+-dependent exchange and retention of gamma-aminobutyric acid by mouse brain subcellular particles.
Topics: Adsorption; Aminobutyrates; Animals; Biological Transport; Brain; Carbon Isotopes; Chlorpromazine; Imipramine; In Vitro Techniques; Kinetics; Mathematics; Membranes; Mice; Orphenadrine; Potassium Chloride; Receptors, Drug; Sodium Chloride; Time Factors; Tritium | 1971 |
Hiccup.
Topics: Amides; Amitriptyline; Benzoates; Catheterization; Chlorpromazine; Digestive System; Hiccup; Humans; Orphenadrine; Pharynx; Respiratory System | 1971 |
[Statistical reports of the psychopharmacological agents used in the past 10 years in the Ospedale Neuropsichiatrico Provinciale of Mantua].
Topics: Chlorpromazine; Chlorprothixene; Humans; Mental Disorders; Orphenadrine; Pentylenetetrazole; Phenelzine; Phenothiazines; Reserpine; Theophylline; Thioridazine; Tranquilizing Agents | 1967 |
Effects of some centrally-acting drugs in conscious chicks and on spinal reflexes.
Topics: Animals; Carbamates; Chickens; Chlorpromazine; Male; Mephenesin; Meprobamate; Orphenadrine; Pentylenetetrazole; Picrotoxin; Reflex; Spinal Nerves; Strychnine; Triazines | 1968 |
A new method for quantitative grip strength evaluation.
Topics: Animals; Chlormezanone; Chlorpromazine; Diazepam; Fatigue; Meprobamate; Methods; Mice; Muscles; Orphenadrine; Pharmacology | 1969 |
The effect of orphenadrine on neuromuscular transmission.
Topics: Animals; Cats; Chlorpromazine; Decerebrate State; Diaphragm; Muscles; Neuromuscular Junction; Orphenadrine; Phrenic Nerve; Poultry; Rats; Sciatic Nerve | 1965 |
A controlled trial of anti-Parkinson drugs in drug-induced Parkinsonism.
Topics: Adolescent; Adult; Chlorpromazine; Haloperidol; Humans; Middle Aged; Orphenadrine; Parasympatholytics; Parkinson Disease; Parkinson Disease, Secondary; Perphenazine; Schizophrenia; Tranquilizing Agents; Trifluoperazine | 1966 |
Hypoglycaemic coma occurring during treatment with chlorpromazine and orphenadrine.
Topics: Blood Glucose; Chlorpromazine; Coma; Female; Humans; Hypoglycemia; Mental Disorders; Middle Aged; Orphenadrine; Tolbutamide | 1967 |
Anthropometric and pharmacotherapeutic variables on acute emesis induced by cisplatin-containing chemotherapy.
Topics: Acute Disease; Age Factors; Antiemetics; Antineoplastic Agents; Body Weights and Measures; Chlorpromazine; Cisplatin; Cross-Sectional Studies; Dexamethasone; Drug Combinations; Humans; Logistic Models; Metoclopramide; Middle Aged; Multivariate Analysis; Ondansetron; Orphenadrine; Prognosis; Prospective Studies; Sex Factors; Vomiting | 2000 |
[PSYCHIATRIC USE OF SOME PSYCHOPHARMACOLOGICAL DRUGS IN PREGNANCY].
Topics: Chlordiazepoxide; Chlorpromazine; Fetus; Haloperidol; Imipramine; Isocarboxazid; Meprobamate; Nialamide; Orphenadrine; Perphenazine; Pharmacology; Pregnancy; Prochlorperazine; Promazine; Psychopharmacology; Reserpine; Thalidomide; Thioridazine | 1963 |
[MODIFICATIONS OF THE EEG DUE TO PSYCHOPHARMACOLOGICAL TREATMENT. LONG-TERM STUDIES ON MENTAL PATIENTS].
Topics: Bemegride; Chlormethiazole; Chlorpromazine; Electroencephalography; Haloperidol; Humans; Hypnotics and Sedatives; Imipramine; Mental Disorders; Mentally Ill Persons; Meprobamate; Methotrimeprazine; Orphenadrine; Phenothiazines; Prochlorperazine; Psychopharmacology; Sympathomimetics; Trimeprazine | 1963 |
[EFFECT OF DRUG THERAPY ON REHOSPITALIZATIONS AT THE BEL AIR CLINIC OF PATIENTS WITH CHRONIC PSYCHOSES EXCEPT MANIC-DEPRESSIVE PSYCHOSES].
Topics: Bipolar Disorder; Chlorpromazine; Chlorprothixene; Convulsive Therapy; Drug Therapy; Haloperidol; Hospitalization; Humans; Insulin; Methotrimeprazine; Orphenadrine; Phenothiazines; Prognosis; Promazine; Psychotic Disorders; Reserpine; Statistics as Topic; Tranquilizing Agents; Trifluperidol | 1964 |
EFFECT OF IMIPRAMINE AND SOME ANALOGUES ON THE UPTAKE OF 5-HYDROXYTRYPTAMINE BY HUMAN BLOOD PLATELETS IN VITRO.
Topics: Amitriptyline; Antidepressive Agents; Blood Platelets; Chlorpromazine; Desipramine; Humans; Imipramine; In Vitro Techniques; Metabolism; Orphenadrine; Pharmacology; Research; Serotonin | 1964 |
PENETRATION OF LIPID MONOLAYERS BY PSYCHOACTIVE DRUGS.
Topics: Brain Chemistry; Cell Membrane Permeability; Cerebrosides; Chlorpromazine; Gangliosides; Lecithins; Lipids; Meclizine; Meprobamate; Orphenadrine; Phenobarbital; Phosphatidylcholines; Phosphatidylethanolamines; Psychotropic Drugs; Research; Reserpine; Sphingomyelins | 1965 |
TIME-SERIES, FREQUENCY ANALYSIS, AND ELECTROGENESIS OF THE EEGS OF NORMALS AND PSYCHOTICS BEFORE AND AFTER DRUGS.
Topics: Amphetamine; Antidepressive Agents; Barbiturates; Biomedical Research; Caffeine; Central Nervous System Stimulants; Chlordiazepoxide; Chlorpromazine; Deanol; Drug Therapy; Electroencephalography; Lysergic Acid Diethylamide; Meprobamate; Orphenadrine; Pentobarbital; Perphenazine; Pharmacology; Phenobarbital; Placebos; Schizophrenia; Statistics as Topic; Tranquilizing Agents | 1965 |